close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Cough Syrups Ineffective

Billions of dollars wasted? That's what the American College of Chest Physicians (ACCP) is saying about Americans' annual spend on over-the-counter cough remedies. Such medicines have little or not effect on cough symptoms, says the ACCP, who have recently issued new guidelines for cough treatment.

The guidelines were published in the January issue of Chest (journal of the American College of Chest Physicians) and an article about them was published by the Herald-Whig online on January 10, 2006.

The reason non-prescription cough syrups are not effective is that they usually contain the relevant drugs at too low a concentration, or they contain combinations of drugs whose effectiveness in treating coughs has not been proven, said Dr. Richard Irwin, chairman of the group's Cough Guidelines Committee, to the Herald-Whig.

Despite the fact that non-prescription cough syrups claim to offer fast, effective relief, "the best studies that we have to date would suggest there's not a lot of justification for using these medications because they haven't been shown to work," said Irwin, a professor of medicine at the University of Massachusetts Medical School in Worcester, Massachusetts.

And Dr Irwin is not alone in his opinion. "I agree with what the American Academy of Chest Physicians is saying about over-the-counter medications," said Dr Michael Hambrick, a family practice physician with Blessing Physician Services, to the Herald-Whig.

Codeine and dextromethorphan are two drugs that have been shown to relieve symptoms of cough caused by colds. They are often present in non-prescription cough syrups. However, the doses must be adequate to offer that relief.

"The problem is codeine is a narcotic and you don't want to use that liberally," Hambrick said. "Dextromethorphan works, but the dosages (in over-the-counter syrups) are just too small for the most part."

Robitussin is one of the largest-selling over-the-counter cough syrups, and it contains dextromethorphan - a Robitussin ingredient that the US Food and Drug Administration (FDA) has seemed safe and effective, said Francis Sullivan, a spokesman for Wyeth Consumer Healthcare, which makes Robitussin, according to the Herald-Whig.

"[Robitussin] wouldn't be a top brand if people didn't feel it was efficacious," Sullivan reportedly said.

Similarly, the Consumer Healthcare Products Association, a trade group for makers of non-prescription drugs, disputed the guidelines, saying that non-prescription cough medicines provide relief to millions of people annually.

However, the recommendations have been endorsed not only by the ACCP, but also by the American Thoracic Society and the Canadian Thoracic Society.

Risks of Over-the-Counter Cough Syrups

Delaying seeking professional treatment for coughs is one risk of using over-the-counter cough syrups for coughs caused by colds, according to Irwin. This can be particularly dangerous for more serious coughs, such as whooping cough.

The new guidelines advise that adults up to age 65 years receive a new adult vaccine for whooping cough that was approved last year.

Additional symptoms should be a warning signal. "The key is if you're having shortness of breath or fever or chest pain, those are things that should cue you in that your cough is more serious," Hambrick said. "A great number of (coughs) are serious and need to be treated with something more than cough medicines."

Another risk is drowsiness. Many popular non-prescription cough syrups claim not to cause drowsiness, but according to Irwin this is because they contain none of the older antihistamines that help relieve coughs caused by colds. Such antihistamines, including diphenhydramine, which is an active ingredient in Benadryl, are also available without a prescription, although they are not marked as cough medicines.

According to Hambrick, coughs related to colds are usually caused by postnasal drip, which would be easily alleviated by an antihistamine.

"But those [antihistamines] have significant side effects," Hambrick says, according to the Herald-Whig. "Most people get very sleepy with Benadryl."

For coughs lasting more than three weeks, Dr Edward Schulman, a representative of the American Thoracic Society on the guidelines panel, said people should consult their health professionals - similarly, the additional symptom of shortness of breath could indicate other serious conditions, such as pneumonia.

For coughs due to colds, which normally last less than three weeks, drinking fluids can help, and so can chicken soup, Schulman reportedly said.

Source:
Report: Cough syrups don't work, Quincy Herald-Whig online, January 10, 2006.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...